Oncologix Tech Stock Today
| OCLG Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 87
|
Oncologix Tech is trading at 1.0E-4 as of the 29th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Oncologix Tech has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Oncologix Tech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of December 2022 and ending today, the 29th of November 2024. Click here to learn more.
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. The company has 340.13 M outstanding shares. More on Oncologix Tech
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Oncologix Pink Sheet Highlights
| President | Harold Halman |
| Business Concentration | Health Care, Health Care Providers & Services, Shell Companies, Financial Services (View all Sectors) |
Oncologix Tech [OCLG] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 612.23 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oncologix Tech's market, we take the total number of its shares issued and multiply it by Oncologix Tech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Oncologix Tech conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 340.13 M outstanding shares.
Oncologix Tech currently holds about 86.31 K in cash with (24.2 K) of positive cash flow from operations.
Check Oncologix Tech Probability Of Bankruptcy
Oncologix Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Oncologix Tech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Oncologix Tech Corporate Executives
Elected by the shareholders, the Oncologix Tech's board of directors comprises two types of representatives: Oncologix Tech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oncologix. The board's role is to monitor Oncologix Tech's management team and ensure that shareholders' interests are well served. Oncologix Tech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oncologix Tech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Kramarz | CFO and Secretary | Profile |
Other Information on Investing in Oncologix Pink Sheet
Oncologix Tech financial ratios help investors to determine whether Oncologix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncologix with respect to the benefits of owning Oncologix Tech security.